Active ingredientAllylestrenolCat. No. P-A084-001CAS 432-60-0Family · Pharmaceutical analytical standards
Allylestrenol
A synthetic progestin described and patented in 1958 and in medical use since the early 1960s; historically used for threatened miscarriage and premature labour, in Japan it has also been used for benign prostatic hyperplasia. This family brings together the active ingredient and other impurities.
Did you know?It is an unusual progestin: it lacks the ketone group at position 3, thought to be important for activity, and is a prodrug that the body converts into the active form.
Go to the active ingredient →Active ingredientAllylestrenolCat. No. P-A084-001CAS 432-60-0
ImpurityAllylestrenol Impurity BCat. No. P-A084-002
ImpurityEstr-4-en-17-oneCat. No. P-A084-003CAS 3646-28-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.